HCPCS code J9317 — Sacituzumab govitecan-hziy. Status: Active. Effective Jan 1, 2021. Source: CMS HCPCS Level II.

J9317

Active

Sacituzumab govitecan-hziy

Injection, sacituzumab govitecan-hziy, 2.5 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jan 1, 2021
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9376

MUE — Medically Unlikely Edits

Maximum units of J9317 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 648
Practitioner Services 648

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
55135-0132-01 Trodelvy

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2021-Q1
    Sacituzumab govitecan-hziy